Interventional oncology is a subspecialty of cancer care that uses image-guided, minimally invasive procedures to treat tumors deep inside the body. Rather than open surgery or whole-body chemotherapy, interventional oncologists insert thin needles, probes, or catheters through tiny incisions in the skin and guide them to a tumor using real-time imaging. The field is often called the “fourth pillar” of cancer treatment, standing alongside surgical oncology, medical oncology, and radiation oncology.
How Image Guidance Works
Every interventional oncology procedure depends on imaging to see inside the body in real time. CT scans, ultrasound, MRI, and fluoroscopy (a type of live X-ray) let the physician pinpoint the exact location of a tumor and guide instruments to it with millimeter-level precision. This targeting is what allows the procedures to destroy cancer cells while minimizing damage to surrounding healthy tissue. In some cases, imaging is also used during the procedure to monitor the treatment zone as it forms, so the physician can confirm the tumor is being fully covered.
Ablation: Destroying Tumors in Place
Ablation is the most recognizable category of interventional oncology. Instead of cutting a tumor out, the physician inserts a probe directly into it and destroys the cells using extreme heat, extreme cold, or electrical energy. Several techniques exist, each suited to different tumor types and locations.
Radiofrequency Ablation
Radiofrequency ablation (RFA) uses a needle-like electrode that delivers high-frequency electrical current into the tumor. This creates rapid vibration of ions in the tissue, generating frictional heat that raises the temperature to 60–100°C. At those temperatures, cellular proteins break apart and the tissue dies. If the temperature exceeds 100°C, the tissue around the electrode can char, which actually reduces the ablation’s effectiveness. RFA has been used for decades in the liver, kidney, and lung.
Microwave Ablation
Microwave ablation works on a similar principle but uses electromagnetic waves to heat tissue. It can reach higher temperatures faster than RFA and create larger treatment zones, which makes it increasingly popular for bigger tumors or situations where speed matters.
Cryoablation
Cryoablation takes the opposite approach, using extreme cold to form an ice ball around the tumor. The freeze-thaw cycle ruptures cancer cells. One advantage is that the ice ball is visible on imaging during the procedure, giving the physician a clear view of exactly how much tissue is being treated. A study of cryoablation in patients with stage I non-small cell lung cancer who couldn’t undergo surgery found a 5-year survival rate of roughly 68% and a progression-free survival rate of about 88%.
Irreversible Electroporation
Irreversible electroporation (IRE) is a non-thermal technique that delivers short, intense electrical pulses to punch tiny permanent holes in cancer cell membranes, causing the cells to die. Because it doesn’t rely on heat or cold, IRE is especially useful when tumors sit near blood vessels, nerves, or other sensitive structures that could be damaged by temperature extremes. It’s often used for prostate cancer, where tumors may be close to the urethra or rectum. Avoiding thermal injury in those areas lowers the risk of side effects like erectile dysfunction and urinary incontinence.
Intra-arterial Therapies: Treating Tumors Through Blood Vessels
Some cancers, particularly liver cancers, receive most of their blood supply from a single artery. Interventional oncologists exploit this by threading a thin catheter through the blood vessels and delivering treatment directly into the artery feeding the tumor. This concentrates the therapy at the tumor site while largely sparing the rest of the body.
Chemoembolization
Transarterial chemoembolization (TACE) delivers chemotherapy directly to a liver tumor and then blocks the blood vessel supplying it. The conventional approach mixes a chemotherapy solution with an oily substance, followed by tiny particles that physically plug the artery. A newer version uses drug-eluting beads: microspheres loaded with chemotherapy that release the drug slowly over days. Either way, the tumor gets hit twice, by the drug and by the loss of its blood supply.
Radioembolization
Radioembolization (also called TARE) takes a different approach to the same delivery route. Instead of chemotherapy, tiny radioactive microspheres labeled with yttrium-90 are injected into the artery feeding the tumor. These microspheres, just 20 to 60 micrometers across, lodge in the small blood vessels within the tumor and emit radiation over a short range. Yttrium-90 has a half-life of about 64 hours, meaning most of the radiation is delivered within the first few days. Two types of microspheres are available, glass and resin, which differ in how much radiation they deposit. The glass version typically delivers a higher absorbed dose to the liver tissue.
Where Interventional Oncology Fits in Cancer Treatment
Interventional oncology procedures are rarely used in isolation. Interventional oncologists serve on multidisciplinary treatment teams alongside surgeons, medical oncologists, radiation oncologists, hepatologists, radiologists, and pathologists. For hepatocellular carcinoma (the most common type of primary liver cancer), national treatment guidelines specifically recommend this kind of multidisciplinary team and list intra-arterial therapies as standard treatment options alongside surgery, transplant, and systemic drug therapy.
The role of interventional oncology varies by cancer type and stage. For small tumors in the liver, kidney, or lung, ablation may be a primary treatment, particularly for patients who aren’t good candidates for surgery due to age, other health conditions, or tumor location. In more advanced liver cancer, chemoembolization or radioembolization may be used to control tumor growth, either as a standalone treatment or as a bridge while a patient waits for a liver transplant. These procedures can also be combined with immunotherapy or targeted drug therapy.
What Recovery Looks Like
One of the biggest practical differences between interventional oncology and traditional surgery is recovery time. Most procedures are performed through a small skin puncture rather than a large incision, and many are done on an outpatient basis or with just an overnight hospital stay. Most patients can return to their normal routine the next day, though some feel tired for a few days to a week afterward.
Pain is most common in the first three days but can linger up to a week. After embolization procedures in particular, patients may experience what’s called post-embolization syndrome: a combination of fatigue, nausea, and pain that varies in severity depending on the person and the specific therapy. These symptoms are generally managed with medication and resolve on their own. Compared to the weeks of recovery typical after major abdominal surgery, the lighter recovery burden is a significant factor in treatment decisions, especially for older patients or those with other medical conditions.
Beyond Tumor Treatment
Interventional oncology also plays a role in cancer care that goes beyond directly destroying tumors. Image-guided biopsies, where a needle is guided into a suspicious mass using CT or ultrasound, are a routine part of cancer diagnosis. Interventional oncologists also place ports and central venous catheters for chemotherapy delivery, drain fluid collections caused by cancer, and perform procedures to relieve pain or obstruction caused by tumor growth. These supportive procedures often improve quality of life and keep other cancer treatments on track.